Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases
Molecular Therapy · 2026-08 · 34 (8) · 4379-4381
DOI: 10.1016/j.ymthe.2026.07.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-08. Verfasst von Wen Zeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Health Medicine and Behavioural Science, The University of Queensland, Brisbane, QLD, Australia. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHMRC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Frazer Institute, Faculty of Health Medicine and Behavioural Science, The University of Queensland, Brisbane, QLD, Australia.
- Frazer Institute, Faculty of Health Medicine and Behavioural Science, The University of Queensland, Brisbane, QLD, Australia; Ian Frazer Centre for Children's Immunotherapy Research, Child Health Research Centre, Facult…
Förderung
- NHMRC
Zitieren
APA
Zeng, W., Yu, D., & Canete, P. F. (2026). Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases. Molecular Therapy, 34(8), 4379-4381. https://doi.org/10.1016/j.ymthe.2026.07.014
Vancouver
Zeng W, Yu D, Canete PF. Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases. Molecular Therapy. 2026;34(8):4379-4381. doi:10.1016/j.ymthe.2026.07.014
BibTeX
@article{Zeng2026,
author = {Zeng, Wen and Yu, Di and Canete, Pablo F},
title = {Neuritin’s potential as a new therapeutic target for diverse autoimmune diseases},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {8},
pages = {4379--4381},
doi = {10.1016/j.ymthe.2026.07.014}
}
EUVIMED